These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. LncRNA AZIN1-AS1 ameliorates myocardial ischemia-reperfusion injury by targeting miR-6838-5p/WNT3A axis to activate Wnt-β/catenin signaling pathway. Zhang G, Ding L, Sun G, Liu Z, Ou W, Wang B, Sun Y. In Vitro Cell Dev Biol Anim; 2022 Jan; 58(1):54-68. PubMed ID: 35064471 [Abstract] [Full Text] [Related]
11. The lncRNA, H19 Mediates the Protective Effect of Hypoxia Postconditioning Against Hypoxia-Reoxygenation Injury to Senescent Cardiomyocytes by Targeting microRNA-29b-3p. Zhang X, Cheng L, Xu L, Zhang Y, Yang Y, Fu Q, Mi W, Li H. Shock; 2019 Aug; 52(2):249-256. PubMed ID: 29958242 [Abstract] [Full Text] [Related]
15. Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling. Yuan M, Meng XW, Ma J, Liu H, Song SY, Chen QC, Liu HY, Zhang J, Song N, Ji FH, Peng K. Drug Des Devel Ther; 2019 Aug; 13():3137-3149. PubMed ID: 31564830 [Abstract] [Full Text] [Related]
18. Downregulation of lncRNA ZFAS1 protects H9c2 cardiomyocytes from ischemia/reperfusion‑induced apoptosis via the miR‑590‑3p/NF‑κB signaling pathway. Huang P, Yang D, Yu L, Shi Y. Mol Med Rep; 2020 Sep; 22(3):2300-2306. PubMed ID: 32705215 [Abstract] [Full Text] [Related]